Immunotherapy in indolent Non-Hodgkin's Lymphoma

Treatment of non-Hodgkin lymphoma (NHL) in general has improved over the years with the emergence of the monoclonal antibodies (MAB) therapy. NHL is divided into B cell NHL and T cell NHL. Treatment of NHL was based on the subtype of NHL and its staging. NHL is divided into aggressive and indolent N...

Descripción completa

Detalles Bibliográficos
Autores principales: Amhaz, Ghid, Bazarbachi, Ali, El-Cheikh, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160834/
https://www.ncbi.nlm.nih.gov/pubmed/35663281
http://dx.doi.org/10.1016/j.lrr.2022.100325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160834/
https://www.ncbi.nlm.nih.gov/pubmed/35663281
http://dx.doi.org/10.1016/j.lrr.2022.100325

Ejemplares similares